Protein remains a top target as food M&A turns selective

Protein is still the cleanest check a buyer can write

Food M&A may be cooler than it was in the boom years, but protein has not lost its shine. The reason is simple: buyers are no longer chasing size for size’s sake, they are chasing assets that solve a real consumer problem, and protein still does that better than most ingredient themes. It reaches across better-for-you snacking, functional beverages, and formulation platforms, which gives strategics more than one reason to lean in.

That matters in a market where the easy money is gone. Larger companies are pruning noncore businesses and putting their capital toward growth categories tied to wellness, value, and convenience. Protein fits that filter because it can pull multiple levers at once: nutrition, taste, platform innovation, and category expansion. In plain English, it is not just a claim anymore. It is a capability.

Why protein keeps showing up on the shopping list

PMCF Investment Banking says protein has emerged as a highly sought-after category because demand has moved well beyond the old powder-and-bar playbook. That is the real shift worth watching. Consumers are not only looking for protein in obvious fitness products, they are expecting it in everyday food and drink, which widens the pool of assets that can justify a strategic premium.

PMCF also points to the new diligence lens: ingredient sourcing, regulatory risk, and long-term brand alignment matter more now. That is a useful clue for where the smart money goes. Buyers want protein businesses that can scale without creating headaches, and they want brands that can live inside a larger portfolio without diluting it.

The trade-off is obvious. Commodity protein looks ordinary; protein with a story, a supply chain, and a credible place in a consumer’s weekly routine looks valuable.

The assets that still attract attention

The most attractive protein targets today are the ones that can do more than add grams to a label. Ingredient platforms are in the sweet spot because they can be plugged into multiple categories, from drinks to bars to refrigerated formats. Functional nutrition brands are right there too, especially when they use protein as part of a broader wellness pitch rather than as a one-note claim.

Brand-led consumer plays also still matter, but only when they bring pricing power. PitchBook says food and beverage M&A is increasingly favoring premium assets with pricing power, especially in functional drinks and protein snacks. That is exactly where buyers are willing to spend because those businesses can defend margin and travel well across channels.

You can see that logic in how big companies are building around the edges of their core. Some are refreshing cereals with more protein and functional formats. Others are working cleaner labels and globally inspired flavors into condiments. The common thread is not just health, but specificity: products that feel current, useful, and worth a premium.

The deal examples tell the story better than the headlines

The transactions that closed in 2025 show what a selective market actually rewards. PepsiCo completed its acquisition of poppi on May 19, 2025 for $1.95 billion, including $300 million of anticipated cash tax benefits for a net purchase price of $1.65 billion. That is not a random soda buy. It is a play for a beverage brand with a wellness angle and enough consumer pull to justify a serious valuation.

Celsius made a similar move when it announced on February 20, 2025 that it would acquire Alani Nutrition for $1.8 billion, including $150 million in tax assets, for a net purchase price of $1.65 billion. Again, the signal is clear: buyers will pay when a brand sits at the intersection of energy, functionality, and lifestyle relevance.

Flowers Foods followed the same script when it completed its acquisition of Simple Mills on February 21, 2025. Flowers said the deal would increase its presence in better-for-you and attractive snacking segments, which is exactly how a strategic buyer should think about protein-adjacent brands. The point is not just more revenue. It is a stronger position in a category consumers already trust.

Why the demand story still has legs

The consumer side is doing its share of the work. The International Food Information Council’s 2025 survey found that a high-protein diet was the most common diet Americans followed in the past year, and consumers used 'good source of protein' as the top criterion for defining a healthy food. That is the kind of signal buyers notice, because it suggests protein has crossed from niche wellness language into mainstream buying behavior.

Cargill’s 2025 Protein Profile backs that up: 61% of Americans increased their protein intake in 2024, up from 48% in 2019. That is a big enough jump to matter, especially when paired with the broader market view that protein is still growing at a mid-single-digit CAGR over the next decade. When a category can show steady consumer adoption and credible growth forecasts at the same time, strategics tend to keep it on the short list.

PitchBook’s estimate that food and beverage M&A was headed toward about $120 billion in 2025 adds the final piece. The market is not dead. It is selective. Premium assets with real differentiation can still command attention, while plain-vanilla businesses are left explaining why they deserve a look.

What this means for the next wave of buyers

The best protein deals are no longer about bulk or broad reach alone. They are about assets that can move from claim to platform, from ingredient to brand story, and from trend to repeat purchase. That is why protein still sits near the top of the strategic shopping list even as the rest of food M&A slows down.

If you want to know whether a protein asset is worth serious money, the test is straightforward: does it have sourcing discipline, a clean regulatory profile, a brand consumers already buy into, and a use case that travels across multiple products? If the answer is yes, it still looks like one of the safest places to deploy capital in a cautious market.